Phase 3 SOPHIA Study - 102337

Spotlight
Video

Phase 3 SOPHIA Study

Loading........
Description: Scott Koenig discusses the Phase 3 SOPHIA study.

About MacroGenics, Inc.

MacroGenics is a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer. The Company generates its pipeline of product candidates primarily from its proprietary suite of next-generation antibody-based technology platforms, which have applicability across broad therapeutic domains. The combination of MacroGenics' technology platforms and protein engineering expertise has allowed the Company to generate promising product candidates and enter into several strategic collaborations with global pharmaceutical and biotechnology companies. For more information, please see the Company's website at www.macrogenics.com.... MacroGenics and the MacroGenics logo are trademarks or registered trademarks of MacroGenics, Inc.
Shared By : Annual-Meeting
Posted on : 06/07/19
Added : 19 days ago
Category : Breast Cancer